购物车
- 全部删除
- 您的购物车当前为空
Edrecolomab (Panorex) 是靶向细胞表面糖蛋白 17-1A 的鼠源抗体,具有抗肿瘤活性,可识别人肿瘤相关抗原 Ep-CAM,可用于研究结直肠癌。
为众多的药物研发团队赋能,
让新药发现更简单!
Edrecolomab (Panorex) 是靶向细胞表面糖蛋白 17-1A 的鼠源抗体,具有抗肿瘤活性,可识别人肿瘤相关抗原 Ep-CAM,可用于研究结直肠癌。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,320 | 现货 | |
5 mg | ¥ 5,780 | 现货 | |
10 mg | ¥ 7,830 | 现货 | |
25 mg | ¥ 11,600 | 现货 | |
50 mg | ¥ 15,600 | 现货 |
产品描述 | Edrecolomab (Panorex) is a murine monoclonal antibody targeting the cell surface glycoprotein 17-1A, exhibiting antitumor activity by recognizing the human tumor-associated antigen Ep-CAM. It is used in studies of colorectal cancer. |
体外活性 | Edrecolomab 显著抑制人结肠癌 HT-29 系肿瘤的生长。[1] |
体内活性 | Edrecolomab (30μg /dose,静脉注射)处理,在 HT-29 裸鼠模型中抑制肿瘤的生长。[1] |
别名 | 依决洛单抗, Panorex, M-17-1A, CO17-1A, CO171A, 17-1A, 1083 17-1A |
CAS No. | 156586-89-9 |
存储 | store at low temperature | store at -20°C | Shipping with blue ice. |
评论内容